McKesson Corp. wants out—of Oklahoma state court, that is. The drug distributor filed papers in Oklahoma state court Feb. 27 seeking to get the Cherokee Nation’s lawsuit against it moved to federal court in the Eastern District of Oklahoma.
Counsel to the Cherokee Nation are calling foul and say the drug distributor, which distributes one-third of all pharmaceuticals used in North America, is playing procedural games.
Counsel for the Cherokee Nation, William Ohlemeyer of Boies Schiller Flexner LLP and Richard Fields of Fields PLLC, say McKesson’s true goal is to have the case transferred to a consolidated proceeding in Ohio state court “far from the Cherokee Nation’s home.”
In January, the Cherokee Nation filed a lawsuit in Oklahoma state court against McKesson, Cardinal Health Inc., AmerisourceBergen, CVS Health, Walgreens Boots Alliance Inc., and Wal-Mart Stores Inc., claiming the companies caused and perpetuated the opioid prescription drug abuse epidemic in the Cherokee Nation.
McKesson’s latest move comes after the drug distributor persuaded the U.S. District Court for the Northern District of Oklahoma to not let the case proceed in tribal court.
“McKesson continues to use every tool they have to delay the inevitable outcome of this case and avoid litigating in Oklahoma which has the highest per capita rate of opioid distribution in the country,” Fields said in a Feb. 28 statement.
“It is time for McKesson and the other opioid distributors and retailers to be held accountable for failing to meet their legal and ethical obligations to restrict opioids to those with legitimate medical needs,” Ohlemeyer added.
Bloomberg Law contacted McKesson for comment but no one from the company responded.
Stay on top of new developments in health law and regulation, and learn more, by signing up for a free trial to Bloomberg Law.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)